Mosunetuzumab in DLBCL Shows Promise as Frontline Option for Elderly Patients

By News Health
50 minutes Ago

(MedPage Today) — At the recent American Society of Hematology (ASH) meeting, researchers presented early data from a phase II study evaluating mosunetuzumab (Lunsumio) as frontline monotherapy for elderly patients with diffuse large B-cell lymphoma…

Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/119036

Author :

Publish date : 2025-12-16 15:38:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

AI Model Stratifies Late Recurrence Risk in HR-Positive Breast Cancer

Don't Overlook Chikungunya: Prevention Tips for Physicians With Traveling Patients

Nick Reiner's Struggle With Drugs; Mifepristone in Drinking Water; Vax Warning Nixed

Treating Adolescent Obesity: Early Intervention Is Vital

Higher Cost, Worse Coverage: ACA Enrollees Say Expiring Subsidies Will Hit Them Hard

One way to deal with OCD and intrusive thoughts